|
WDR76 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.883200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.886200E-01 |
| Normal-vs-Stage2 |
2.518600E-01 |
| Normal-vs-Stage3 |
7.861000E-01 |
| Normal-vs-Stage4 |
9.472000E-01 |
| Stage1-vs-Stage2 |
6.998400E-02 |
| Stage1-vs-Stage3 |
8.314200E-01 |
| Stage1-vs-Stage4 |
9.453600E-01 |
| Stage2-vs-Stage3 |
8.201900E-02 |
| Stage2-vs-Stage4 |
1.814840E-01 |
| Stage3-vs-Stage4 |
8.389800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.888600E-01 |
| Normal-vs-AfricanAmerican |
2.732600E-01 |
| Normal-vs-Asian |
9.168600E-01 |
| Caucasian-vs-AfricanAmerican |
2.663000E-01 |
| Caucasian-vs-Asian |
9.867000E-01 |
| AfricanAmerican-vs-Asian |
2.990800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.059000E-01 |
| Normal-vs-Female |
8.552600E-01 |
| Male-vs-Female |
2.157000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.699400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.790600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.520000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.000200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.319600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.799000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.194000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.609200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.506600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.481400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.921200E-01 |
| Classical-VS-Follicular |
1.282420E-03 |
| Classical-VS-Other |
3.590400E-01 |
| Classical-VS-Normal |
6.424400E-01 |
| Tall-VS-Follicular |
4.495400E-03 |
| Tall-VS-Other |
1.285410E-01 |
| Tall-VS-Normal |
2.125200E-01 |
| Follicular-VS-Other |
8.772400E-01 |
| Follicular-VS-Normal |
1.143160E-01 |
| Other-VS-Normal |
5.938600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.848600E-01 |
| Normal-vs-N1 |
9.069800E-01 |
| N0-vs-N1 |
7.924000E-01 |
|
|
